Structure to function relationships in ceruloplasmin: A 'moonlighting' protein

Cellular and Molecular Life Sciences

Volumn 59, Issue 9, 2002, Pages 1413-1427

  Bielli, P ^a   Calabrese, L ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Ceruloplasmin; Copper metabolism; Electron transfer; Iron metabolism; Moonlighting protein; Multicopper oxidase

Indexed keywords

CERULOPLASMIN; COPPER; MOONLIGHTING PROTEIN; OXIDOREDUCTASE; UNCLASSIFIED DRUG;

BINDING SITE; ELECTRON TRANSPORT; ENZYME MECHANISM; HUMAN; HUMAN CELL; METABOLIC REGULATION; METAL BINDING; MOLECULAR EVOLUTION; OXYGEN AFFINITY; PATHOPHYSIOLOGY; PLASTICITY; PROTEIN STRUCTURE; REVIEW; STRUCTURE ACTIVITY RELATION;

ANIMALS; BINDING SITES; CERULOPLASMIN; COPPER; HUMANS; MODELS, MOLECULAR; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; STRUCTURE-ACTIVITY RELATIONSHIP;

VERTEBRATA;

EID: 0036709869     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-002-8519-2     Document Type: Review

References (146)

1. Holmberg C. G. and Laurell C. B. (1948) Investigation serum copper. II. Isolation of the copper containing protein, and a description of some its properties. Acta. Chem. Scand. 2: 550-556
2. Rice E. W. (1961) Evaluation of the role of ceruloplasmin as an acute-phase reactant. Clin. Chim. Acta. 6: 652-655
3. Frieden E. and Hsieh H. S. (1976) Ceruloplasmin: The copper transport protein with essential oxidase activity. Adv. Enzymol. 44: 187-236
4. Ryden L. G. (1984) Ceruloplasmin. In: Copper Proteins and Copper Enzymes, vol. 3, pp. 37-60, Lontie L. (ed.), CRC, Boca Raton, Fla
5. Malkin R. and Malmstrom B. G. (1970) The state and function of copper in biological systems. Adv. Enzymol. Relat. Mol. Biol. 33: 177-244
6. Yoshida K., Furihata K., Takeda S., Nakamura A., Yamamoto K., Morita H. et al. (1995) A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nat. Genet. 9: 267-272
7. Harris Z. L., Takahashi Y., Miyajima H., Serizawa M., MacGillivray R. T. A. and Gitlin J. D. (1995) Aceruloplasminemia: Molecular characterization of a novel disorder of iron metabolism. Proc. Natl. Acad. Sci. USA 92: 2539-2543
8. Zaitseva I., Zaitsev V., Card G., Moshkov K., Bax B., Ralph A. et al. (1996) The X-ray structure of human ceruloplasmin at 3.1 Å: Nature of the copper centres. J. Biol. Inorg. Chem. 1: 15-23
9. Takahashi Y., Miyajima H., Shirabe S., Nagataki S., Suenaga A. and Gitlin J. D. (1996) Characterization of a nonsense mutation in the ceruloplasmin gene resulting in diabetes and neurodegenerative disease. Hum. Mol. Genet. 5: 81-84
10. Jeffery C. J. (1999) Moonlighting proteins. Trends Biochem. Sci. 24: 8-11
11. Malmstrom B. G. (1982) Enzymology of oxygen. Annu. Rev. Biochem. 51: 21-59
12. Farver O. and Pecht I. (1997) Electron transfer reactions in multi-copper oxidases. In: Multi-Copper Oxidases, pp. 355-389, Messerschmidt A. (ed.), World Scientific Publication, Singapore
13. Solomon E. I., Sundaram U. M. and Machonkin T. E. (1996) Multicopper oxidase and oxygenases. Chem. Rev. 96: 2563-2605
14. Holm R. H., Kennepohl P. and Solomon E. I. (1996) Structural and functional aspects of metal site in biology. Chem. Rev. 96: 2239-2314
15. Silva D. M. de, Askwith C. C., Eide D. and Kaplan J. (1995) The Fet3 gene product required for high affinity iron transport in yeast is a cell surface ferroxidase. J. Biol. Chem. 270: 1098-1101
16. Grass G. and Rensing C. (2001) CueO is a multi-copper oxidase that confers copper tolerance in Escherichia coli. Biochem. Biophys. Res. Commun. 286: 902-908
17. Farver O., Wherland S. and Pecht I. (1994) Intramolecular electron transfer in ascorbate oxidase is enhanced in the presence of oxygen. J. Biol. Chem. 269: 22933-22936
18. Allendorf M. D., Spira D. J. and Solomon E. J. (1985) Low-temperature magnetic circular dichroism studies of native laccase: Spectroscopic evidence for exogenous ligand bridging at a trinuclear copper active site. Proc. Natl. Acad. Sci. USA 82: 3063-3067
19. Calabrese L., Carbonaro M. and Musci G. (1988) Chicken ceruloplasmin: Evidence in support of a trinuclear cluster involving type 2 and 3 copper centers. J. Biol. Chem. 263: 6480-6483
20. Calabrese L., Carbonaro M. and Musci G. (1989) Presence of coupled trinuclear copper cluster in mammalian ceruloplasmin is essential for efficient electron transfer to oxygen. J. Biol. Chem. 264: 6183-6187
21. Messerschmidt A., Rossi A., Ladenstein R., Huber R., Bolognesi M., Gatti G. et al. (1989) X-ray crystal strucure of the blue oxidase from zucchini: Analysis of the polypeptide fold and a model of the copper sites and ligands. J. Mol. Biol. 206: 513-529
22. Ducros V., Brzozowski A. M., Wilson K. S., Brown S. H., Ostergaard P., Schneider P., et al. (1998) Crystal structure of the type-2 Cu depleted laccase from Coprinus cinereus at 2.2 Å resolution. Nat. Struct. Biol. 5: 310-316
23. Malmstrom B. G., Andreasson L. E. and Reinhammar B. (1975) Copper-containing oxidases and superoxide dismutase. In: The Enzymes, vol. 12B, pp. 507-579, Boyer P. D. (ed.), Academic Press, New York
24. 2+ centres in human ceruloplasmin. Eur. J. Biochem. 197: 185-189
25. Calabrese L., Mateescu M. A., Carbonaro M. and Mondovi B. (1988) Reexamination of spectroscopic properties of ceruloplasmin freshly isolated with a novel very rapid single-step procedure. Biochem. Int. 16: 199-208
26. Musci G., Carbonaro M., Adriani A., Lania A., Galtieri A. and Calabrese L. (1990) Unusual stability properties of a reptilian ceruloplasmin. Arch. Biochem. Biophys. 279: 8-13
27. Musci G., Bonaccorsi di Patti M. C. and Calabrese L. (1995) Modulation of the redox state of the copper sites of human ceruloplasmin by chloride. J. Prot. Chem. 14: 611-617
28. Musci G., Bonaccorsi di Patti M. C., Fagiolo U. and Calabrese L. (1993) Age related changes in human ceruloplasmin. J. Biol. Chem. 268: 13388-13395
29. Machonkin T. E. and Solomon E. I. (2000) The thermodynamics, kinetics and molecular mechanism of intramolecular electron transfer in human ceruloplasmin. J. Am. Chem. Soc. 122: 12547-12560
30. Musci G., Bellenchi G. C. and Calabrese L. (1999) The multifunctional oxidase activity of ceruloplasmin as revealed by anion binding studies. Eur. J. Biochem. 265: 589-597
31. Messerschmidt A. and Huber R. (1990) The blue oxidases, ascorbate oxidase, laccase and ceruloplasmin: Modelling and structural relationships. Eur. J. Biochem. 187: 341-352
32. Adman E. T. (1991) Structure and function of copper-containing proteins. Curr. Opin. Struct. Biol. 1: 895-904
33. Murphy M. E. P., Lindley P. F. and Aisen P. (1997) Structural comparison of cupredoxin domains: Domain recycling to construct proteins with novel functions. Prot. Sci. 6: 761-770
34. Ortel T. L., Takahashi N. and Putnam F. W. (1984) Structural model of human ceruloplasmin based on internal triplication, hydrophilic/hydrophobic character, and secondary structure of domains. Proc. Natl. Acad. Sci. USA 81: 4761-4765
35. Ryden L. G. and Hunt L. T. (1993) Evolution of protein complexity: The blue copper-containing oxidases and related proteins. J. Mol. Evol. 36: 41-66
36. Messerschmidt A., Ladenstein R., Huber R., Bolognesi M., Avigliano L., Rossi A. et al. (1992) Refined crystal structure of ascorbate oxidase at 1.9 Å resolution. J. Mol. Biol. 224: 179-205
37. Bonaccorsi di Patti M. C., Pascarella S., Catalucci D. and Calabrese L. (1999) Homology modeling of the multicopper oxidase FET3 gives new insights in the mechanism of iron transport in yeast. Prot. Eng. 12: 895-897
38. Takahashi N., Ortel T. L. and Putnam F. W. (1984) Singlechain structure of human ceruloplasmin: The complete amino acid sequence of the whole molecule. Proc. Natl. Acad. Sci. USA 81: 390-394
39. Lindley P., Card G., Zaitseva I., Zaitsev V., Reinhammar B., Selin-Lindgren E. et al. (1997) An X ray structural study of human ceruloplasmin in relation to ferroxidase activity. J. Biol. Inorg. Chem. 2: 454-463
40. Gunnarsson P. O., Nylen U. and Pettersson G. (1973) Effect of pH on electron-paramagnetic-resonance spectra of ceruloplasmin. Eur. J. Biochem. 37: 47-50
41. Ryden L. G. and Bjork I. (1976) Reinvestigation of some physicochemical and chemical properties of human ceruloplasmin (ferroxidase). Biochemistry 15: 3411-3417
42. Musci G., Bonaccorsi di Patti M. C. and Calabrese L (1993) The state of the copper sites in human ceruloplasmin. Arch. Biochem. Biophys. 306: 111-118
43. Machonkin T. E., Zhang H. H., Hedman B., Hodgson K. O. and Solomon E. I. (1998) Spectroscopic and magnetic studies of human ceruloplasmin: Identification of a permanently reduced type 1 copper site. Biochemistry 37: 9570-9578
44. Bielli P., Bellenchi G. C. and Calabrese L. (2001) Site-directed mutagenesis of human ceruloplasmin: Production of a proteolytically stable protein and structure-activity relationships of type 1 sites. J. Biol. Chem. 276: 2678-2685
45. Farver O. and Pecht I. (1981) Electron transfer processes of blue copper proteins. In: Copper Proteins, vol. 3, pp 153-189, Spiro G. T. (ed.) Princeton University, Princeton, N. J.
46. Zaitsev V. N., Zaitseva I., Papiz M. and Lindley P. F. (1999) An X-ray crystallographic study of the binding sites of the azide inhibitor and organic substrates to ceruloplasmin. J. Biol. Inorg. Chem. 4: 579-587
47. Faraggi M. and Pecht I. (1973) The electron pathway to Cu(II) in ceruloplasmin. J. Biol. Chem. 248: 3146-3149
48. Farver O., Bendahl L., Skov L. K. and Pecht I. (1999) Human ceruloplasmin: Intramolecular electron transfer kinetics and equilibration. J. Biol. Chem. 274: 26135-26140
49. Holtzman N. A. and Gaumnitz B. M. (1970) Studies on the rate of release and turnover of ceruloplasmin and apoceruloplasmin in rat plasma. J. Biol. Chem. 245: 2354-2358
50. Gitlin J. D., Schroeder J. J., Lee-Ambrose L. M. and Cousins R. J. (1992) Mechanims of caeruloplasmin biosynthesis in normal and copper-deficient rats. Biochem. J. 282: 835-839
51. Harris E. D. (1991) Copper transport: An overview. Proc. Soc. Exp. Biol. Med. 196: 130-140
52. Lockhart P. J. and Mercer J. F. B. (1999) Cloning and expression analysis of the sheep ceruloplasmin cDNA. Gene 236: 251-257
53. Bonaccorsi di Patti M. C., Musci G., Giartosio A., D'Alessio S. and Calabrese, L. (1990) The multidomain structure of ceruloplasmin from calorimetric and limited proteolysis studies. J. Biol. Chem. 265: 21016-21022
54. Sato M. and Gitlin J. D. (1991) Mechanisms of copper incorporation during the biosynthesis of human ceruloplasmin. J. Biol. Chem. 266:5128-5134
55. Terada K., Kawarada Y., Miura N., Yasui O., Koyama K. and Sugiyama T. (1995) Copper incorporation in ceruloplasmin rat livers. Biochim. Biophys. Acta. 1270: 58-62
56. Hellman N. E., Kono S., Miyajima H. and Gitlin J. D. (2002) Biochemical analysis of a missense mutation in aceruloplasminemia. J. Biol. Chem. 277: 1375-1380
57. Patel B. N. and David S. (1997) A novel glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian astrocytes. J. Biol. Chem. 272: 20185-20190
58. Salzer J., Lovejoy L., Linder M. C. and Rosen C. (1998) Ran2, a glial lineage marker, is a GPI-anchored form of ceruloplasmin. J. Neurosci. Res. 54: 147-157
59. Patel B. N., Dunn R. J. and David S. (2000) Alternative RNA splicing generates a glycosylphosphatidylinositol-anchored form of ceruloplasmin in mammalian brain. J. Biol. Chem. 275: 4305-4310
60. Fortna R. R., Watson H. A. and Nyquist S. E. (1999) Glycosyl phosphatidylinositol-anchored ceruloplasmin is expressed by rat Sertoli cells and is concentrated in detergent-insoluble membrane fractions. Biol. Reprod. 61: 1042-1049
61. Musci G., Di Marco S., Bellenchi G. C. and Calabrese L. (1996) Reconstitution of ceruloplasmin by the Cu (I)-glutathione complex. J. Biol. Chem. 271: 1972-1978
62. Chelly J., Tumer Z., Tonnesen T., Petterson A., Ishikawa-Brush Y., Tommerup N. et al. (1993) Isolation of a candidate gene for Menkes disease that encodes a potential heavy metal binding protein. Nat. Genet. 3: 14-19
63. Mercer J. F. B., Livingston J., Hall B., Paynter J. A., Begy C., Chandrasekharappa S. et al. (1993) Isolation of a partial candidate gene for Menkes disease by positional cloning. Nat. Genet. 3: 20-25
64. Vulpe C., Levinson B., Whitney S., Packman S. and Gitschier J. (1993) Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper transporting ATPase. Nat. Genet. 3: 7-13
65. Bull P. C., Thomas G. R., Rommens J. M., Forbe J. R. and Cox D. W. (1993) The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat. Genet. 5: 327-337
66. Tanzi R. E., Petrukhin K., Chernov I., Pellequer J. L., Wasco W., Ross B. et al. (1993) The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat. Genet. 5: 344-350
67. Valentine J. S. and Gralla E. B. (1997) Delivering copper inside yeast and human cells. Science 278: 817-818
68. Pena M. M. O., Lee J. and Thiele D. J. (1999) A delicate balance: Homeostatic control of copper uptake and distribution. J. Nutr. 129N: 1251-1260
69. Lee J., Prohaska J. R. and Thiele D. J. (2001) Essential role for mammalian copper transporter Ctrl in copper homeostasis and embryonic development. Proc. Natl. Acad. Sci. USA 98: 6842-6847
70. Hamza I., Faisst A., Prohaska J., Chen J., Gruss P. and Gitlin J. D. (2001) The metallochaperone Atox1 plays a critical role in perinatal copper homeostasis. Proc. Natl. Acad. Sci. USA 98: 6848-6852
71. Schaefer M., Hopkins R. G., Failla M. L. D. and Gitlin J. D. (1999) Hepatocyte-specific localization and copper-dependent trafficking in the Wilson's disease protein in the liver. Am. J. Physiol. 276: C639-C646
72. Ehrenwald E. and Fox P. L. (1994) Isolation of nonlabile human ceruloplasmin by chromatographic removal of a plasma metalloproteinase. Arch. Biochem. Biophys. 309: 392-395
73. Calabrese L. and Musci G. (1997) Molecular properties of ceruloplasmin from different species. In: Multi-Copper Oxidase, pp. 23-80, Messerschmidt A. (ed.), World Scientific, Singapore
74. Stevens M. D., Di Silvestro R. A. and Harris E. D. (1984) Specific receptor for ceruloplasmin in membrane fragments from aortic and heart tissues. Biochemistry 23: 261-266
75. Kataoka M. and Tavassoli M. (1984) Ceruloplasmin receptors in liver cell suspensions are limited to the endothelium. Exp. Cell Res. 155: 232-240
76. Kataoka M. and Tavassoli M. (1985) Identification of ceruloplasmin receptors on the surface of human blood monocytes, granulocytes, and lymphocytes. Exp. Hematol. 13: 806-810
77. Dini L., Carbonaro M., Musci G. and Calabrese L. (1990) The interaction of ceruloplasmin with Kupffer cells. Eur. J. Cell Biol. 52: 207-212
78. Morita H., Ikeda S., Yamamoto K., Morita S., Yoshida K., Nomoto S. et al. (1995) Hereditary ceruloplasmin deficiency with hemosiderosis: A clinicopathological study of a Japanese family. Ann. Neurol. 37: 64-656
79. Cha M. K. and Kim I. H. (1999) Ceruloplasmin has a distinct active site for the catalyzing glutathione-dependent reduction of alkyl hydroperoxide. Biochemistry 38: 12104-12110
80. Park Y. S., Suzuki K., Taniguchi N. and Gutteridge J. M. C. (1999) Glutathione peroxidase-like activity of caeruloplasmin as an important lung antioxidant. FEBS Lett. 458: 13-136
81. Mukhopadhyay, C. K., Mazumder B., Lindley P. F. and Fox P. L. (1997) Identification of the prooxidant site of human ceruloplasmin: A model for oxidative damage by copper bound to the protein surfaces. Proc. Natl. Acad. Sci. USA 94: 1154611551
82. Mukhopadhyay C. K. and Fox P. L. (1998) Ceruloplasmin copper induces oxidant damage by a redox process utilizing cell-derived superoxide as reductant. Biochemistry 37: 14222-14229
83. Fox P. L., Mazumder B., Ehrenwald E. and Mukhopadhyay C. K. (2000) Ceruloplasmin and cardiovascular disease. Free Radic. Biol. Med. 28: 1735-1744
84. Glass G. A. and Stark A. A. (1997) Promotion of glutathionegamma-glutamyl transpeptidase-dependent lipid peroxidation by copper and ceruloplasmin: The requirement for iron and the effects of antioxidants and antioxidant enzymes. Environ. Mol. Mutagen. 29: 73-80
85. Inoue K., Akaike T., Miyamoto Y., Okamoto T., Sawa T., Otagiri M. et al. (1999) Nitrosothiol formation catalyzed by ceruloplasmin: Implication for cytoprotecive mechanism in vivo. J. Biol. Chem. 274: 27069-27075
86. Akaike T. (2000) Mechanisms of biological S-nitrosation and its measurement. Free Radic. Res. 33: 461-469
87. Moriel P., Pereira I. R., Bertolami M. C. and Abdalla D. S. (2001) Is ceruloplasmin an important catalyst for S-nitrosothiol generation in hypercholesterolemia? Free Radic. Biol. Med. 30: 318-326
88. Torres J. and Wilson M. T. (1999) The reaction of copper proteins with nitric oxide. Biochim. Biophys. Acta. 1411: 310-322
89. Musci G., Di Marco S., Bonaccorsi di Patti M. C. and Calabrese L. (1991) Interaction of nitric oxide with ceruloplasmin lacking an EPR-detectable type 2 copper. Biochemistry 30: 9866-9872
90. Cappelli-Bigazzi M., Ambrosio G., Musci G., Battaglia C., Bonaccorsi di Patti M. C., Golino P. et al. (1997) Ceruloplasmin impairs endothelium-dependent relaxation of rabbit aorta. Am. J. Physiol. 273: H2843-H2849
91. Curzon G. (1967) The oxidation of N,N-dimethyl-p-phenilendiamine by oxidizing agents and by ceruloplasmin. Biochem. J. 103: 289-295
92. Walaas E. and Walaas O. (1961) Oxidation of reduced phosphopyridine nucleotides by p-phenilendiamines, catecholamines and serotonin in the presence of ceruloplasmin. Arch. Biochem. Biophys. 95: 151-162
93. Walaas E., Walaas O. and Lovstad R. A. (1963) The influence of catecholamines on visible absorption and on electron spin resonance absorption spectrum of ceruloplasmin. Acta. Physiol. Scand. 17: S263-S269
94. Gunnarsson P. O., Pettersson G. and Pettersson I. (1970) pH-dependence of the ceruloplasmin catalyzed oxidation of dimethyl-p-phenylenediamine. Eur. J. Biochem. 17: 586-592
95. Young S. N. and Curzon G. (1972)A method for obtaining linear reciprocal plots with caeruloplasmin and its application in a study of the kinetic parameters of caeruloplasmin substrates. Biochem. J. 129: 273-283
96. Wrona M. Z. and Dryhurst G. (1991) Interactions of 5-hydroxytryptamine with oxidative enzymes. Biochem. Pharmacol. 41: 1145-1162
97. Rescigno A., Rinaldi A. C. and Sanjust E. (1998) Some aspects of tyrosine secondary metabolism. Biochem. Pharmacol. 56: 1089-1096
98. Floris G., Medda R., Padiglia A. and Musci G. (2000) The physiopathological significance of ceruloplasmin: A possible therapeutic approach. Biochem. Pharmacol. 60: 1735-1741
99. Lovstad R. A. (1972) Interaction of ceruloplasmin with L- and D-dopa. Acta. Chem. Scand. 26: 2832-2836
100. Medda R., Calabrese L., Musci G., Padiglia A. and Floris G. (1996) Effect of ceruloplasmin on 6-hydroxydopamine oxidation. Biochem. Mol. Biol. Int. 38: 721-72
101. McDermott J. A., Huber C. T., Osaki S. and Frieden E. (1968) Role of iron in the oxidase activity of ceruloplasmin. Biochim. Biophys. Acta. 151: 541-557
102. Huber C. T. and Frieden E. (1970) Substrate activation and the kinetics of ferroxidase. J. Biol. Chem. 245: 3973-3978
103. De Ley M. and Osaki S. (1975) Intramolecular electron transport in human ferroxidase (caeruloplasmin). Biochem. J. 151: 561-566
104. Osaki S., Johnson D. A. and Frieden E. (1966) The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum. J. Biol. Chem. 241: 2746-2751
105. Osaki S., Johnson D. A. and Frieden E. (1971) The mobilization of iron from the perfused mammalian liver by a serum copper enzyme, ferroxidase I. J. Biol. Chem. 246: 3018-3023
106. Fleming R. E. and Sly W. S. (2001) Ferroportin mutation in autosomal dominant hemochromatosis: Loss of function, gain in understanding. J. Clin. Invest. 108: 521-522
107. Silva D. M. de, Askwith C. C. and Kaplan J. (1996) Molecular mechanism of iron uptake in eukaryotes. Physiol. Rev. 76: 31-47
108. Halliwell, B. and Gutteridge, J. M. C. (1984) Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem. J. 219: 1-14
109. Harris Z. L., Durley A. P., Man T. K. and Gitlin J. D. (1999) Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. Med. Sci. 96: 10812-10817
110. Montosi G., Donovan A., Totaro A., Garuti C., Pignatti E., Cassanelli S. et al. (2001) Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J. Clin. Invest. 108: 619-623
111. Vulpe C. D., Kuo Y. M., Murphy T. L., Cowley L., Askwith C., Libina N. et al. (1999) Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in sla mouse. Nat. Genet. 21: 195-199
112. Miyajima H., Takahashi Y., Kamata T., Shimizu H., Sakai N. and Gitlin J. D. (1997) Use of desferrioxamine in the treatment of aceruloplasminemia. Ann. Neurol. 41: 404-407
113. Hubel C. A., Kozlov A. V., Kagan V. E., Evans R. W., Davidge S. T., McLaughlin M. K. et al. (1996) Decreased transferring and increased transferrin saturation in sera of women with preeclampsia: Implications for oxidative stress. Am. J. Obstet. Gynecol. 175: 692-700
114. Vitoratos N., Salamalekis E., Dalamaga N., Kassanos D. and Creatsas G. (1999) Defective antioxidant mechanisms via changes in serum ceruloplasmin and total iron binding capacity of serum in women with pre-eclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol. 84: 63-67
115. Klomp L. W. J., Farhangrazi Z. S., Dugan L. L. and Gitlin J. D. (1996) Ceruloplasmin gene expression in the murine central nervous systems. J. Clin. Invest. 98: 207-215
116. Klomp L. W. and Gitlin J. D. (1996) Expression of ceruloplasmin gene in the human retina and brain: Implications for a pathogenic model in aceruloplasminemia. Hum. Mol. Genet. 5: 1989-1996
117. Gitlin J. D. (1988) Transcriptional regulation of ceruloplasmin gene expression during inflammation. J. Biol. Chem. 263: 6281-6287
118. Ramadori G., Van Damme J., Rieder H. and Meyer zum Buschenfelde K. H. (1988) Interleukin 6, the third mediator of acute-phase reaction, modulates hepatic protein synthesis in human and mouse: Comparison with interleukin 1 beta and tumor necrosis factor-alpha. Eur. J. Immunol. 18: 12591264
119. Tovey L. A. and Lathe G. H. (1968) Caeruloplasmin and green plasma in women taking oral contraceptives, in pregnant women, and in patients with rheumatoid arthritis. Lancet 14: 596-600
120. Fleming R. E. and Gitlin J. D. (1990) Primary structure of rat ceruloplasmin and analysis of tissue-specific gene expression during development. J. Biol. Chem. 265: 7701-7707
121. Fleming R. E., Whitman I. P. and Gitlin J. D. (1991) Induction of ceruloplasmin gene expression in rat lung during inflammation and hyperoxia. Am. J. Physiol. 260: L68-L74
122. Mazumder B. and Fox P. L. (1999) Delayed translational silencing of ceruloplasmin transcript in gamma interferon-activated U937 monocytic cells: Role of the 3′ untranslated region. Mol. Cell. Biol. 19: 6898-6905
123. Gabay C. and Kushner I. (1999) Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 340: 448-454
124. Andrews G. S. (1979) Studies of plasma zinc, copper, caeruloplasmin, and growth hormone: With special reference to carcinoma of the bronchus. J. Clin. Pathol. 32: 325-333
125. Larsen B., Heron I. and Thorling E. B.(1980) Elevated serum Cu in Hodgkin's disease and inhibitory effects of ceruloplasmin on lymphocyte response in vitro. Eur. J. Cancer 16: 415-421
126. Linder M. C., Moor J. R. and Wright K. (1981) Ceruloplasmin assays in diagnosis and treatment of human lung, breast, and gastrointestinal cancers. J. Natl. Cancer Inst. 67: 263-275
127. Knekt P., Aromaa A., Maatela J., Rissanen A., Hakama M., Aaran R. K. et al. (1992) Serum ceruloplasmin and the risk of cancer in Finland. Br. J. Cancer 65: 292-296
128. Arumanayagam M., Wong F. W., Rogers M. and Swaminathan R. (1993) Serum ceruloplasmin, plasma copper concentration and copper to ceruloplasmin ratio in cervical carcinoma. Gynecol. Obstet. Invest. 35: 175-178
129. Kunapuli S. P., Singh H., Singh P. and Kumar A. (1987) Ceruloplasmin gene expression in human cancer cells. Life Sci. 40: 2225-2228
130. Hough C. D., Sherman-Baust C. A., Pizer E. S., Montz F. J., Im D. D., Rosenshein N. B. et al. (2000) Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. Cancer Res. 60: 6281-6287
131. Nishie A., Masuda K., Otsubo M., Migita T., Tsuneyoshi M., Kohno K. et al. (2001) High expression of the Cap43 gene in infiltrating macrophages of human renal cell carcinomas. Clin. Cancer Res. 7: 2145-2151
132. Pousset D., Piller V., Bureaud N. and Piller F. (2001) High levels of ceruloplasmin in the serum of transgenic mice developing hepatocellular carcinoma. Eur. J. Biochem. 268: 1491-1499
133. Stassar M. J., Devitt G., Brosius M., Rinnab L., Prang J., Schradin T. et al. (2001) Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization. Br. J. Cancer 85: 1372-1382
134. Ehrenwald E., Chisolm G. M. and Fox P. L. (1994) Intact human ceruloplasmin oxidatively modifies low density lipoprotein. J. Clin. Invest. 93: 1493-1501
135. Bianchini A., Musci G. and Calabrese L. (1999) Inhibition of endothelial nitric oxide synthase by ceruloplasmin. J. Biol. Chem. 274: 20265-20270
136. Folkman J. and Klagsbrun M. (1987) Angiogenic factors. Science 235: 442-447
137. Raju K. S., Alessandri G., Ziche M. and Gullino P. M. (1982) Ceruloplasmin, copper ions, and angiogenesis. J. Natl. Cancer Inst. 69: 1183-1188
138. Duyndam M. C., Hulscher T. M., Fontijn D., Pinedo H. M. and Boven E. (2001) Induction of vascular endothelial growth factor expression and hypoxia-inducible factor lalpha protein by the oxidative stressor arsenite. J. Biol. Chem. 276: 48066-48076
139. Mukhopadhyay C. K., Mazumder B. and Fox P. L. (2000) Role of hypoxia-inducible factor-1 in transcriptional activation of ceruloplasmin by iron deficiency. J. Biol. Chem. 275: 21048-21054
140. Brown N. S. and Bicknell R. (2001) Hypoxia and oxidative stress in breast cancer. Oxidative stress: Its effects on the growth, metastatic potential and response to therapy of breast cancer. Breast Cancer Res. 3: 323-327
141. Hough C. D., Cho R. K., Zonderman A. B., Schwartz D. R. and Morin P. J. (2001) Coordinately up-regulated genes in ovarian cancer. Cancer Res. 61: 3869-3876
142. Senra Valera. A., Lopez Saez J. J. and Quintela Senra D. (1997) Serum ceruloplasmin as a diagnostic marker of cancer. Cancer Lett. 121: 139-145
143. Brewer G. J., Dick R. D., Grover D. K., LeClaire V., Tseng M., Wicha M. et al. (2000) Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study. Clin. Cancer Res. 6: 1-10
144. 99Mo-labelled sodium tetrathiomolybdate after duodenal administration in sheep: The effect on caeruloplasmin (EC 1. 16. 3. 1) diamine oxidase activity and plasma copper. Br. J. Nutr. 43: 515-523
145. Young S. N. and Courzon G. (1974) Neonatal human ceruloplasmin. Biochim. Biophys. Acta. 336: 306-308
146. Bingle C. D., Epstein O., Srai S. K. S. and Gitlin J. D. (1991) Hepathic caeruloplasmin-gene expression during development in the guinea-pig: Correlation with changes in hepatic copper metabolism. Biochem. J. 276: 771-775